Ads
    Related paper
  1. Glycemic Variability in Diabetic Patients Adding Canagliflozin 300Mg to their Underlying Treatment
  2. Glycemic Variability and Associated Individual and Clinical Factors among Type 2 Diabetic Patients Attending Out-Patient Clinic at Diabetes Center of Excellence in Kenya (Formally Diabetic Comprehensive Care Clinic)
  3. EFFECT OF PERIODONTAL TREATMENT ON GLYCEMIC CONTROL OF DIABETIC PATIENTS WITH CHRONIC PERIODONTITIS
  4. Association between the glycemic variability and mortality in critically ill neurological patients - A hospital based observational study
  5. Correlation between Red Cell Distribution Width and Glycemic Control in Diabetic Patients
  6. Glycemic Variability in Postoperative Major Oncosurgery Patients and its Effect on Patient Outcomes - A Prospective Observational Study
  7. ASSOCIATION BETWEEN VITAMIN D LEVELS AND GLYCEMIC CONTROL AMONG ADULT DIABETIC PATIENTS IN AHSA, SAUDI ARABIA
  8. Level of Glycemic Control and Its Associated Factors among Type II Diabetic Patients in Debre Tabor General Hospital, Northwest Ethiopia
  9. Summary of chromatographic analysis methods of anti diabetic gliflozins Empagliflozin, Canagliflozin and Dapagliflozin
  10. FASTING C-PEPTIDE INDEX MAY BE THE STRONGEST PREDICTOR FOR DETECTING EFFECTIVENESS OF GLYCEMIC CONTROL BY GLP-1 ANALOGUE, LIRAGLUTIDE THERAPY FOR JAPANESE TYPE 2 DIABETIC PATIENTS